Tylicki, 133 patient vitamin D prophylaxis study: 14% lower mortality [p=0.61] https://c19p.org/tylicki
copied to clipboard
Predictors of Mortality in Hemodialyzed Patients after SARS-CoV-2 Infection
et al., Journal of Clinical Medicine, doi:10.3390/jcm11020285
Retrospective 133 COVID+ hemodialysis patients in Poland, showing lower mortality with existing vitamin D use, without statistical significance.
|
risk of death, 14.4% lower, RR 0.86, p = 0.61, treatment 28 of 85 (32.9%), control 25 of 48 (52.1%), NNT 5.2, adjusted per study, odds ratio converted to relative risk, multivariable.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Tylicki et al., 1/6/2022, retrospective, Poland, Europe, peer-reviewed, 10 authors, study period 6 October, 2020 - 28 February, 2021, dosage not specified.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.